Divalproex Sodium Tablet, Film Coated, Extended Release
Product Images NDC 71610-157

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 71610-157). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 150 mg (71610 0157 60)

Divalproex Sodium ER 250 mg tablet bottle label showing 90 extended release film-coated tablets. The label states storage instructions, manufacturer as Aurobindo Pharma Limited (Hyderabad, India), and repackager as Aphena Pharma Solutions - Tennessee, LLC. The label includes NDC 71610-0157-60 and notes prescription use only.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Figure 1 (Divalproex Fig1)

A cumulative response curve chart showing percent reduction in CPS rate on the vertical axis and percent of patients on the horizontal axis. Two curves compare Divalproex sodium delayed-release tablets and placebo, depicting patient improvement and worsening outcomes as measured by CPS rate reduction.*

FDA Label Image

Figure 2 (Divalproex Fig2)

This figure is a chart depicting the percentage reduction in CPS (clinical parameter scale) rate on the vertical axis against the percentage of patients on the horizontal axis for high dose and low dose Divalproex Sodium delayed-release tablets. The chart compares patient outcomes demonstrating improvement or worsening across doses.*

FDA Label Image

Figure-3 (Divalproex Fig3)

A bar chart comparing values between placebo and Divalproex Sodium Extended-Release Tablets. The vertical axis represents a numerical scale from 0 to 1.2. The placebo bar reaches 0.6, while the Divalproex Sodium bar reaches 1.2, with a noted p-value of 0.006 indicating statistical significance between the groups.*

FDA Label Image

Structure (Divalproex Str)

Chemical structure of divalproex sodium, showing its polymeric compound with repeating units featuring sodium and carboxylate groups linked to alkyl chains.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.